Advances in Bile Acid Metabolites and Their Receptor-Targeted Interventions in Chronic Kidney Disease
Chronic kidney disease (CKD) has traditionally been understood from a glomerular perspective: proteinuria and a decline in estimated glomerular filtration rate (eGFR) are regarded as core hallmarks of the disease, and current intervention options for CKD are limited.Recent studies have highlighted the critical role of the gut-kidney axis in the pathogenesis and management of CKD; metabolomics has shown that the accumulation of conjugated bile acids is associated with declining renal function and cardiovascular risk, whereas elevated levels of primary bile acids are associated with a lower risk of the disease.Research data, primarily from animal and cell culture models, indicate that bile acids (BAs) can influence CKD through the nuclear farnesoid X receptor (FXR) and the membrane G protein-coupled bile acid receptor (TGR5),This article provides a systematic review centered on the gut-kidney-vascular axis mediated by bile acid metabolites, elucidating the mechanisms of bile acid homeostasis remodeling and tissue damage in CKD, and highlighting that disease modification requires simultaneous targeting of specific bile acid subtypes and their receptors, rather than relying solely on existing therapies.
Authors
- Jiangwa Xing (ORCID: https://orcid.org/0000-0002-5251-8659)
- Yi You
- Mingxiao Wang
Institutions
- Zunyi Medical University (CN)
Publication Details
- Journal
- Medicine insights.
- Published
- 2026-11-18
- DOI
- https://doi.org/10.70088/8ksgw627
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00